Talvey 40 mg/1.0 ml, Injektionslösung

7680690490027 CH-69049 Injektionslösung
Talvey 40 mg/1.0 ml, Injektionslösung
Talvey 40 mg/1.0 ml, Injektionslösung
Talvey 40 mg/1.0 ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/08/2025
Summary of Product Characteristics
Français
07/08/2025
Summary of Product Characteristics
Italien
07/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.25 MG Substance HBESI

Reimbursement information

Public price
CHF 4704.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
69049
Drug name
Talvey, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FX29
Authorization status
B
Dispensing category
A
First authorization
30/10/2023
Authorization expiration date
31/12/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Package details

Description (FR)
TALVEY sol inj 40 mg/ml flac 1 ml
Description (DE)
TALVEY Inj Lös 40 mg/ml Durchstf 1 ml
Market launch
30/10/2023
Narcotic (BTM)
No

Other package sizes (1)

TALVEY sol inj 3 mg/1.5ml flac 1.5 ml
1 DUR
GTIN: 7680690490010
View